Description
An acute autoimmune process following pharyngitis caused by streptococcal infection. Diagnostic criteria
for rheumatic fever are based on the modified Jones criteria. Has defined high risk population recognizing variability in clinical presentation and had included Echocardiography as a tool to diagnose for subclinical carditis.
Table 45 Modified 2015 Jones’ criteria
Major |
Minor |
Carditis (clinical or subclinical) |
Monoarthralgia |
Arthritis – monoarthritis or polyarthritis |
Fever (≥ 38.0ºC) |
Polyarthralgia |
ESR ≥ 30 mm/hour and/or CRP ≥ 3.0 mg/dl |
Chorea |
Prolonged PR interval (after considering the differences related to age: if there is no carditis as a major criterion) |
Erythema marginatum |
|
Subcutaneous nodules |
|
ESR – erythrocyte sedimentation rate; CRP – C-reactive protein (Adapted from ref 13). All patients with ARF should have an Echocardiography done even in the absence of clinical suspicion of valvular done.
Two major manifestations plus evidence of preceding streptococcal infection OR one major and two minor
manifestations plus evidence of preceding streptococcal infection are required to make a diagnosis
Investigations
• FBC/DC
• ESR/CRP
• Throat swab culture for Streptoccal
• Anti Streptolysin O titres (ASOT)
• ECG
• ECHO
• CXR
Treatment
• Benzathine penicillin IM injection 600 000 IU - 1.2 MU stat OR
• Oral phenoxymethyl penicillin 10-12.5mg/kg/dose twice daily for ten days maximum 500mg every 6
hours.
• Patients with hypersensitivity to penicillin can be treated with oral first generation cephalosporins
for 10 days.
• Treat chorea (if severe)
• Anti- heart failure medication (see section of CCF)
• Relieve symptoms, Bed rest, Relief of arthritis, pain and fever with Anti-inflammatory Agent
Table 46 Management of Acute Rheumatic Fever (ARF)
|
Arthritis |
Carditis |
Prednisolone 2 mg/kg/day |
Nil |
2 – 4 weeks |
Aspirin 50 to 60 mg/kg/day in four to six divided doses |
1 – 2 weeks |
Until symptoms subside |
Ibuprofen 30 mg/kg/day in 3 divided doses, where Aspirin not tolerated |
Until symptoms subside |
Until symptoms subside |
NB: The dose of prednisolone should be 2 mg/kg/day (max 60 mg); then taper by 20–25% per week. Aspirin can be reduced to 25 to 30 mg/kg/day when symptoms improve. The dose of prednisolone should be tapered, and aspirin started during the final week.
Management of Sydenham’s chorea
• Reduce physical and emotional stress and use protective measures as indicated.
• Benzathine penicillin IM stat (Eradicate GAS), then every 28 days for secondary prophylaxis.
Anti-inflammatory agents not indicated.
For severe chorea, any of the following drugs may be used:
• Carbamazepine 7–20 mg/kg/day (7–10 mg/kg day usually sufficient) given TDS PO until chorea is
controlled for at least 2 weeks, then trial off medication
• Valproic acid Usually 15–20 mg/kg/day (can increase to 30 mg/kg/day) given TDS PO until chorea is
controlled for at least 2 weeks, then trial off medication.
• Phenobarbitone, Haloperidol and Chlorpromazine can be used when above not available.
Further management plan
• ARF register (cardiac clinic), issue Acute Rheumatic Fever (ARF)prophylaxis card
• Education of patient and family
• Dental examination
• Long term secondary prophylaxis plan
Secondary prophylaxis to prevent recurrent ARF is a long term, regular administration of antibiotics to:
• Prevent group A β-Haemolytic Streptococcal (GAS) pharyngitis.
• Prevent repeated development of ARF.
• Prevent development of Rheumatic heart disease (RHD)
• Reduce severity of RHD
• Help reduce the risk of death from severe RHD
Antibiotic regimens for secondary prophylaxis
Table 47 Antibiotic regimens for secondary prophylaxis
Antibiotic |
Dose |
Route |
Frequency |
First line |
|||
Benzathine Penicillin G |
1,200,000 U (900 mg) ≥ 30 Kg 600,000 U (450 mg) ≤30 Kg |
Deep IM Injection |
4-weekly |
Second line (If IM route is not possible or refused, adherence should be carefully monitored) |
|||
Phenoxymethylpenicillin (Pen V) |
250mg |
Oral |
Once daily |
Following documented penicillin allergy |
|||
Erythromycin |
250mg |
Oral |
Twice daily |
NOTE: Duration of prophylaxis in all persons with ARF is for a minimum of 10 years after the most recent episode of ARF or until age 21 years (whichever is longer). For RHD, the duration of prophylaxis is for life.